Skip to main content
. 2025 May 27;312(3):755–764. doi: 10.1007/s00404-025-08064-w

Table 4.

Use and handling of non-invasive fetal test systems

Characteristics N (%)
Offer of first-trimester screening parallel to non-invasive prenatal test
 Yes 27 (71.05)
 No 0 (0)
 Optional 11 (28.95)
Offer of non-invasive prenatal testing in a two-stage procedure before first trimester screening
 Yes 6 (15.79)
Offer of non-invasive prenatal testing from a certain threshold after completion of the first trimester screening
> 1:1000 10 (26.32)
> 1:500 11(28.95)
> 1:100 11(28.95)
 No 6 (15.79)
Offer of non-invasive prenatal testing after informed consent without performing first-trimester screening
 Yes 15 (39.47)
The following question pertains to the provision of a non-invasive prenatal test
 Trisomy 21, 13 and 18 8 (21.1)
 Trisomy 21, 13 and 18, monosomy and fetal sex 24 (63.16)
 Other diseases such as Di-George syndrome 6 (15.79)